• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )

    3.430 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.430
    Bid (Size) 2.880 (1)
    Ask (Size) 3.520 (2)
    Prev. Close 3.430
    Today's Range 3.430 - 3.430
    52wk Range 3.350 - 20.50
    Shares Outstanding 4,063,081
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -74.21%
    -74.21%
    1 Month
    -30.92%
    -30.92%
    3 Month
    -47.58%
    -47.58%
    6 Month
    -51.88%
    -51.88%
    1 Year
    -82.76%
    -82.76%

    More News

    Read More
    Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Achieves ISO 13485 Certification
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Positive Nasdaq Listing Decision
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Funding Agreement with Existing Investors
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.